See more : Reliance Power Limited (RPOWER.NS) Income Statement Analysis – Financial Results
Complete financial analysis of Bright Health Group, Inc. (BHG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Bright Health Group, Inc., a leading company in the Medical – Healthcare Plans industry within the Healthcare sector.
- SGS SA (SGSN.SW) Income Statement Analysis – Financial Results
- Micro Focus International plc (MCRO.L) Income Statement Analysis – Financial Results
- Havells India Limited (HAVELLS.BO) Income Statement Analysis – Financial Results
- High Fusion Inc. (SPLIF) Income Statement Analysis – Financial Results
- Kinetik Holdings Inc. (KNTK) Income Statement Analysis – Financial Results
Bright Health Group, Inc. (BHG)
About Bright Health Group, Inc.
Bright Health Group, Inc., a healthcare company, provides health insurance policies in the United States. It operates in two segments, NeueHealth and Bright HealthCare. The NeueHealth segment delivers virtual and in-person clinical care services to patients under contracts through its owned and affiliated primary care clinics. As of December 31, 2021, it worked with approximately 260,000 care provider partners; and operated 180 managed and affiliated risk-bearing clinics within its integrated care delivery system, which included embedded pharmacy, laboratory, radiology, and population health focused specialty services. The Bright HealthCare segment offers commercial and medicare health plan products to consumers in 14 states and 99 markets. The company was formerly known as Bright Health Inc. and changed its name to Bright Health Group, Inc. in February 2021. Bright Health Group, Inc. was incorporated in 2015 and is headquartered in Minneapolis, Minnesota.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.16B | 2.41B | 4.03B | 1.21B | 280.67M | 130.63M |
| Cost of Revenue | 1.28B | 2.21B | 3.95B | 1.05B | 224.39M | 96.41M |
| Gross Profit | -122.92M | 205.79M | 75.72M | 160.02M | 56.29M | 34.23M |
| Gross Profit Ratio | -10.59% | 8.53% | 1.88% | 13.25% | 20.05% | 26.20% |
| Research & Development | 0.00 | 0.00 | 0.00 | 19.43M | 7.24M | 2.54M |
| General & Administrative | 0.00 | 501.84M | 626.36M | 211.75M | 104.22M | 54.48M |
| Selling & Marketing | 0.00 | 82.34M | 287.76M | 96.94M | 49.71M | 26.75M |
| SG&A | 0.00 | 584.18M | 914.11M | 308.69M | 153.93M | 81.23M |
| Other Expenses | 1.74B | 98.28M | 359.76M | 89.50M | 20.45M | 13.09M |
| Operating Expenses | 1.74B | 682.46M | 1.27B | 417.62M | 181.62M | 96.87M |
| Cost & Expenses | 3.02B | 2.89B | 5.23B | 1.46B | 406.01M | 193.27M |
| Interest Income | 0.00 | 12.82M | 7.23M | 0.00 | 0.00 | 0.00 |
| Interest Expense | 38.20M | 12.82M | 7.96M | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 24.17M | 51.36M | 36.71M | 8.29M | 1.13M | 1.03M |
| EBITDA | -1.15B | -425.31M | -1.16B | -249.31M | -124.20M | -61.61M |
| EBITDA Ratio | -98.68% | -17.63% | -28.82% | -20.65% | -44.25% | -47.16% |
| Operating Income | -627.74M | -476.67M | -1.20B | -257.60M | -125.34M | -62.64M |
| Operating Income Ratio | -54.08% | -19.76% | -29.74% | -21.34% | -44.66% | -47.95% |
| Total Other Income/Expenses | -1.43M | -157.61M | -861.96M | -3.80M | 0.00 | 0.00 |
| Income Before Tax | -629.17M | -634.29M | -1.20B | -257.60M | -125.34M | -62.64M |
| Income Before Tax Ratio | -54.20% | -26.30% | -29.90% | -21.34% | -44.66% | -47.95% |
| Income Tax Expense | -1.43M | 3.68M | -26.52M | -9.16M | 8.35M | 3.51M |
| Net Income | -1.20B | -637.97M | -1.18B | -248.44M | -133.69M | -62.64M |
| Net Income Ratio | -103.43% | -26.45% | -29.24% | -20.58% | -47.63% | -47.95% |
| EPS | -150.94 | -81.08 | -240.33 | -145.94 | -79.52 | -37.97 |
| EPS Diluted | -150.94 | -81.08 | -240.33 | -145.94 | -79.52 | -37.97 |
| Weighted Avg Shares Out | 7.95M | 7.87M | 4.90M | 1.70M | 1.68M | 1.65M |
| Weighted Avg Shares Out (Dil) | 7.95M | 7.87M | 4.90M | 1.70M | 1.68M | 1.65M |
5 Outstanding Stocks to Buy That Trade Below $10 and Have Huge Upside Potential
Bright Health Group Reports Second Quarter 2021 Results
Goldman Sachs Starts Coverage on 4 Sizzling Stocks to Buy Now
Bright Health Group to Report Q2 Financial Results
NeueHealth Announces Expansion of its Integrated Care Delivery Model in Florida and Planned Entry into Texas and North Carolina
Hot upstart insurer Bright Health stumbles in its stock-market debut
Bright Health shares slide 5% in trading debut
Source: https://incomestatements.info
Category: Stock Reports